List of Tables
Table 1. Global Kidney Transplant Rejection Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Kidney Transplant Rejection Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Kidney Transplant Rejection Therapeutics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Kidney Transplant Rejection Therapeutics Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Kidney Transplant Rejection Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Kidney Transplant Rejection Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Kidney Transplant Rejection Therapeutics Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Kidney Transplant Rejection Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Kidney Transplant Rejection Therapeutics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Kidney Transplant Rejection Therapeutics, Product Type & Application
Table 12. Global Key Manufacturers of Kidney Transplant Rejection Therapeutics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Kidney Transplant Rejection Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Transplant Rejection Therapeutics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Kidney Transplant Rejection Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Kidney Transplant Rejection Therapeutics Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2020-2025)
Table 19. Global Kidney Transplant Rejection Therapeutics Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2026-2031)
Table 21. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2020-2025)
Table 23. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2026-2031)
Table 25. North America Kidney Transplant Rejection Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Kidney Transplant Rejection Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Kidney Transplant Rejection Therapeutics Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Kidney Transplant Rejection Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Kidney Transplant Rejection Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Kidney Transplant Rejection Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Kidney Transplant Rejection Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Kidney Transplant Rejection Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Kidney Transplant Rejection Therapeutics Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Kidney Transplant Rejection Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Kidney Transplant Rejection Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Kidney Transplant Rejection Therapeutics Sales (K Pcs) by Type (2020-2025)
Table 51. Global Kidney Transplant Rejection Therapeutics Sales (K Pcs) by Type (2026-2031)
Table 52. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2020-2025)
Table 53. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2026-2031)
Table 54. Global Kidney Transplant Rejection Therapeutics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Kidney Transplant Rejection Therapeutics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2020-2025)
Table 57. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2026-2031)
Table 58. Global Kidney Transplant Rejection Therapeutics Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Kidney Transplant Rejection Therapeutics Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Kidney Transplant Rejection Therapeutics Sales (K Pcs) by Application (2020-2025)
Table 61. Global Kidney Transplant Rejection Therapeutics Sales (K Pcs) by Application (2026-2031)
Table 62. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2020-2025)
Table 63. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2026-2031)
Table 64. Global Kidney Transplant Rejection Therapeutics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Kidney Transplant Rejection Therapeutics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2020-2025)
Table 67. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2026-2031)
Table 68. Global Kidney Transplant Rejection Therapeutics Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Kidney Transplant Rejection Therapeutics Price (USD/Pcs) by Application (2026-2031)
Table 70. CSL Limited Company Information
Table 71. CSL Limited Description and Business Overview
Table 72. CSL Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. CSL Limited Kidney Transplant Rejection Therapeutics Product
Table 74. CSL Limited Recent Developments/Updates
Table 75. Digna Biotech, S.L. Company Information
Table 76. Digna Biotech, S.L. Description and Business Overview
Table 77. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product
Table 79. Digna Biotech, S.L. Recent Developments/Updates
Table 80. GlaxoSmithKline Plc Company Information
Table 81. GlaxoSmithKline Plc Description and Business Overview
Table 82. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product
Table 84. GlaxoSmithKline Plc Recent Developments/Updates
Table 85. Grifols, S.A. Company Information
Table 86. Grifols, S.A. Description and Business Overview
Table 87. Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Grifols, S.A. Kidney Transplant Rejection Therapeutics Product
Table 89. Grifols, S.A. Recent Developments/Updates
Table 90. Hansa Medical AB Company Information
Table 91. Hansa Medical AB Description and Business Overview
Table 92. Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Hansa Medical AB Kidney Transplant Rejection Therapeutics Product
Table 94. Hansa Medical AB Recent Developments/Updates
Table 95. Kyowa Hakko Kirin Company Information
Table 96. Kyowa Hakko Kirin Description and Business Overview
Table 97. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product
Table 99. Kyowa Hakko Kirin Recent Developments/Updates
Table 100. Mabtech Limited Company Information
Table 101. Mabtech Limited Description and Business Overview
Table 102. Mabtech Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Mabtech Limited Kidney Transplant Rejection Therapeutics Product
Table 104. Mabtech Limited Recent Developments/Updates
Table 105. Magnus Life Ltd Company Information
Table 106. Magnus Life Ltd Description and Business Overview
Table 107. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product
Table 109. Magnus Life Ltd Recent Developments/Updates
Table 110. Noorik Biopharmaceuticals AG Company Information
Table 111. Noorik Biopharmaceuticals AG Description and Business Overview
Table 112. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product
Table 114. Noorik Biopharmaceuticals AG Recent Developments/Updates
Table 115. Novartis AG Company Information
Table 116. Novartis AG Description and Business Overview
Table 117. Novartis AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Novartis AG Kidney Transplant Rejection Therapeutics Product
Table 119. Novartis AG Recent Developments/Updates
Table 120. Opsona Therapeutics Limited Company Information
Table 121. Opsona Therapeutics Limited Description and Business Overview
Table 122. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product
Table 124. Opsona Therapeutics Limited Recent Developments/Updates
Table 125. OSE Immunotherapeutics Company Information
Table 126. OSE Immunotherapeutics Description and Business Overview
Table 127. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product
Table 129. OSE Immunotherapeutics Recent Developments/Updates
Table 130. Pharmicell Company Information
Table 131. Pharmicell Description and Business Overview
Table 132. Pharmicell Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Pharmicell Kidney Transplant Rejection Therapeutics Product
Table 134. Pharmicell Recent Developments/Updates
Table 135. Pharming Group N.V. Company Information
Table 136. Pharming Group N.V. Description and Business Overview
Table 137. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product
Table 139. Pharming Group N.V. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Kidney Transplant Rejection Therapeutics Distributors List
Table 143. Kidney Transplant Rejection Therapeutics Customers List
Table 144. Kidney Transplant Rejection Therapeutics Market Trends
Table 145. Kidney Transplant Rejection Therapeutics Market Drivers
Table 146. Kidney Transplant Rejection Therapeutics Market Challenges
Table 147. Kidney Transplant Rejection Therapeutics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Kidney Transplant Rejection Therapeutics
Figure 2. Global Kidney Transplant Rejection Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Kidney Transplant Rejection Therapeutics Market Share by Type: 2024 & 2031
Figure 4. Azathioprine Product Picture
Figure 5. Cortina Product Picture
Figure 6. Cyclophosphamide Product Picture
Figure 7. Cyclosporin A Product Picture
Figure 8. Other Product Picture
Figure 9. Global Kidney Transplant Rejection Therapeutics Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Kidney Transplant Rejection Therapeutics Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Clinic
Figure 13. ASCs
Figure 14. Others
Figure 15. Global Kidney Transplant Rejection Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Kidney Transplant Rejection Therapeutics Market Size (2020-2031) & (US$ Million)
Figure 17. Global Kidney Transplant Rejection Therapeutics Sales (2020-2031) & (K Pcs)
Figure 18. Global Kidney Transplant Rejection Therapeutics Average Price (USD/Pcs) & (2020-2031)
Figure 19. Kidney Transplant Rejection Therapeutics Report Years Considered
Figure 20. Kidney Transplant Rejection Therapeutics Sales Share by Manufacturers in 2024
Figure 21. Global Kidney Transplant Rejection Therapeutics Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Kidney Transplant Rejection Therapeutics Players: Market Share by Revenue in Kidney Transplant Rejection Therapeutics in 2024
Figure 23. Kidney Transplant Rejection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Kidney Transplant Rejection Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2020-2031)
Figure 26. North America Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2020-2031)
Figure 30. Europe Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2020-2031)
Figure 31. Germany Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2020-2031)
Figure 38. China Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2020-2031)
Figure 49. Latin America Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Kidney Transplant Rejection Therapeutics by Type (2020-2031)
Figure 59. Global Revenue Market Share of Kidney Transplant Rejection Therapeutics by Type (2020-2031)
Figure 60. Global Kidney Transplant Rejection Therapeutics Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Kidney Transplant Rejection Therapeutics by Application (2020-2031)
Figure 62. Global Revenue Market Share of Kidney Transplant Rejection Therapeutics by Application (2020-2031)
Figure 63. Global Kidney Transplant Rejection Therapeutics Price (USD/Pcs) by Application (2020-2031)
Figure 64. Kidney Transplant Rejection Therapeutics Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
